Clinical usefulness of an ultra-high-sensitivity hepatitis B surface antigen assay to determine the cessation of treatment for HBV reactivation

Clinical usefulness of an ultra-high-sensitivity hepatitis B surface antigen assay to determine the cessation of treatment for HBV reactivation

Introduction and Objectives: We aimed to compare the usefulness of the ultra-high-sensitivity hepatitis B surface antigen (iTACT-HBsAg), high-sensitivity hepatitis B core-related antigen (iTACT-HBcrAg), and anti-HBs assays in determination of cessation of nucleot(s)ide analogue (NA) treatment to pre...

Full description

Saved in:

Bibliographic Details
Main Authors:	Takanori Suzuki, Akihiro Tamori, Kentaro Matsuura, Takako Inoue, Shigeru Kusumoto, Shinya Hagiwara, Haruka Sagi, Atsushi Kaneko, Shuko Murakami, Hayato Kawamra, Kei Fujiwara, Katsumi Aoyagi, Masaru Enomoto, Ritsuzo Kozuka, Hiromi Kataoka, Yasuhito Tanaka
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Annals of Hepatology
Subjects:	Hepatitis B virus (HBV) reactivation High-sensitivity hepatitis B core-related antigen assay (iTACT-HBcrAg) Ultra-high-sensitivity hepatitis B surface antigen assay (iTACT-HBsAg) Anti-HBs
Online Access:	http://www.sciencedirect.com/science/article/pii/S1665268124005477
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Seroepidemiology of hepatitis B virus infection among Chinese schizophrenia patients
by: Huijuan Zhu, et al.
Published: (2015-05-01)

Decreasing hepatitis B seroprevalence in pregnant women in Taiwan between 2016 and 2021: a claim-based cohort study
by: Li-Nien Chien, et al.
Published: (2025-01-01)

Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
by: Lorenzo Piermatteo, et al.
Published: (2023-12-01)

Prevalence and Transfusion Risks of Occult Hepatitis B Infection Among HBcAb-Positive Blood Donors in a High-Endemic Region
by: Ahmed Subeh Alshrari, et al.
Published: (2025-02-01)

Hepatitis B vaccination in Burkina Faso: prevalence of HBsAg carriage and immune response in children in the western region
by: Armel Moumouni Sanou, et al.
Published: (2018-11-01)

Prediction of long-term HBsAg seroclearance in patients with HBeAg-negative chronic hepatitis B
by: Hae Lim Lee, et al.
Published: (2025-07-01)

Exploring using HBsAg to predict interferon treatment course to achieve clinical cure in chronic hepatitis B patients: a clinical study
by: Fei Yan, et al.
Published: (2025-01-01)

Discussion on the duration of response following HBsAg clearance in patients with chronic hepatitis B treated with PegIFNα-2b
by: Tao Wang, et al.
Published: (2025-04-01)

PgRNA closely correlates to cytokine profile in HBeAg-positive pregnant women undergoing prophylactic antiviral intervention
by: Qiao Tang, et al.
Published: (2024-12-01)

Impact of hepatic steatosis on the efficacy of antiviral treatment for chronic hepatitis B and the establishment of predictive model: a cohort study
by: Guanghui Ren, et al.
Published: (2025-02-01)

HBV Hepatitis and Related Renal Nephropathies: Pathogenesis and Treatment
by: Maurizio Salvadori, et al.
Published: (2020-11-01)

Restoration of a functional antiviral immune response to chronic HBV infection by reducing viral antigen load: if not sufficient, is it necessary?
by: Sisi Yang, et al.
Published: (2021-01-01)

A predictive model for functional cure in chronic HBV patients treated with pegylated interferon alpha: a comparative study of multiple algorithms based on clinical data
by: Ya-mei Ye, et al.
Published: (2024-12-01)

SEROPOSITIVITY OF HEPATITIS B AND C AMONG SYRIAN MULTITRANSFUSED PATIENTS WITH HEMOGLOBINOPATHY
by: Widad Yazaji, et al.
Published: (2016-09-01)

Hepatitis B and C infection in HIV-infected children and young adults attending HIV treatment centres in Calabar, Nigeria
by: Joanah Ikobah, et al.
Published: (2024-12-01)

Predictors of HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients treated with nucleotide analogs plus polyethylene glycol interferon
by: Yan Peng, et al.
Published: (2025-01-01)

Development of Low-Cost In-House Assays for Quantitative Detection of HBsAg, HBeAg, and HBV DNA to Enhance Hepatitis B Virus Diagnostics and Antiviral Screening in Resource-Limited Settings
by: Simmone D’souza, et al.
Published: (2025-03-01)

High HBsAg clearance rate and viral dynamics in HBeAg-positive, ALT-normal children and adolescents with chronic HBV infection: results from the prospective sprout project
by: Xin Wang, et al.
Published: (2025-12-01)

TCR-like bispecific antibodies toward eliminating infected hepatocytes in HBV mouse models
by: Yang Shi, et al.
Published: (2024-12-01)

Hepatitis surface B antigen clearance induced by long-term tenofovir disoproxil fumarate monotherapy in chronic hepatitis B treatment: a meta-analysis and longitudinal modeling analysis
by: Weizhe Jian, et al.
Published: (2025-05-01)

Vaccination Status and Influencing Factors of Delayed Vaccination in Toddlers Born to Hepatitis B Surface Antigen-Positive Mothers
by: Jinling Gao, et al.
Published: (2025-03-01)

Occult HBV infection in Chinese blood donors: role of N-glycosylation mutations and amino acid substitutions in S protein transmembrane domains
by: Lu Zhang, et al.
Published: (2019-01-01)

PROFIL ANTI-HBS SEBAGAI PENANDA KEKEBALAN TERHADAP INFEKSI VIRUS HEPATITIS B PADA MAHASISWA KEDOKTERAN
by: Tiara Kasih, et al.
Published: (2017-06-01)

Prevalence of hepatitis B virus infection and associated factors among students living on campus in South-eastern Gabon
by: Augustin Mouinga-Ondeme, et al.
Published: (2025-08-01)

基因工程乙肝疫苗的研制——Ⅲ.MT-5细胞的HBsAg纯化与鉴定
Published: (1990-01-01)

Trend in seroprevalence of Hepatitis B virus infection among blood donors of coastal Karnataka, India
by: Karandeep Singh, et al.
Published: (2009-06-01)

Reevaluating antiviral thresholds in HBV DNA-negative inactive HBsAg carriers: a multicenter histopathological analysis
by: Shan Ren, et al.
Published: (2025-07-01)

Adding pegylated interferon-α to nucleos(t)ide analogs improves HBsAg clearance in chronic hepatitis B with low-level viremia
by: Lilin Wang, et al.
Published: (2025-08-01)

The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment
by: Shengxia Yin, et al.
Published: (2023-12-01)

Transfection of unmodified oligodeoxynucleotide with polyethylenimine reduces the level of hepatitis B surface antigen
by: Junyu Lin, et al.
Published: (2025-05-01)

Key Factors Influencing qHBsAg Dynamics in Chronic Hepatitis B Patients During Treatment with Direct Acting Antivirals
by: Mihai Daniel DODOT, et al.
Published: (2020-03-01)

Seroprevalence of Hepatitis B Surface Antigen among Out Patients Attending a Tertiary Hospital in Kaduna State, Nigeria
by: Uregwu Agnes Edia-Asuke, et al.
Published: (2016-12-01)

HBsAg and anti-HBs coexistence in patients with HBV in acute and chronic phases
by: Zhongshu Pu, et al.
Published: (2025-05-01)

Predicting relapse after achieving a functional cure for chronic hepatitis B (CHB) using baseline HBsAg and end-of-treatment HBsAb levels
by: Lianxiu Han, et al.
Published: (2025-04-01)

PROFIL IMUNITAS TERHADAP VIRUS HEPATITIS B PADA TENAGA KESEHATAN DI RUMAH SAKIT NASIONAL DIPONEGORO SEMARANG
by: Dea Bastiangga, et al.
Published: (2019-10-01)

Protective Antibody Levels Against Hepatitis B among Serodiagnosed Syphilis Cases: Need to Integrate National Control Programs with Immunization Guidelines?
by: Bineeta Kashyap, et al.
Published: (2021-01-01)

Seroprevalence of hepatitis viruses and risk factors in blood donors of Veracruz, Mexico
by: Nayali Lopez-Balderas, et al.
Published: (2015-03-01)

Liver cancer: expression features of hepatitis B antigens
by: V. A. Tumanskiy, et al.
Published: (2013-12-01)

Effects of folic acid supplementation before conception on innate immunity and anti-HBs levels of offspring born to HBsAg-positive mothers
by: Jia Lian, et al.
Published: (2025-04-01)

Determining Hepatitis B Serology After Immune Prophylaxis in Babies of Hepatitis B Surface Antigen Positive Mothers
by: Emine Tekin, et al.
Published: (2021-09-01)